Neuraxis, Inc (NRXS): Shareholders' Equity

Annual figures by period end, from SEC filings.

$3.40M
As of 2025-12-31
$6.74M
As of 2026-06-30
2022-12-31: -$5.57M2023-09-30: -$1.06M2023-12-31: -$1.40M2024-12-31: $2.07M2025-12-31: $3.40M$3.40M
2022-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$3.40M+64.4%2026-03-19, Balance as of period end
2024-12-31$2.07Mn/m2026-03-19, Balance as of period end
2023-12-31-$1.40Mn/a2025-03-20, Balance as of period end
2023-09-30-$1.06Mn/a2024-04-16, Balance as of period end
2022-12-31-$5.57Mn/a2024-04-16, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Neuraxis, Inc (NRXS)2025-12-31$3.40M+64.4%
ADM Tronics Unlimited, Inc. (ADMT)2026-03-31$571.0K-15.0%
Hongchang International Co., Ltd (HCIL)2024-12-31$38.77M-4.2%
Nuwellis, Inc. (NUWE)2025-12-31$2.62M-59.8%
Escalon Medical Corp (ESMC)2025-06-30$1.92M+5.8%
CapsoVision, Inc (CV)2025-12-31$13.26Mn/m
Hyperfine, Inc. (HYPR)2025-12-31$41.01M-16.4%
Guided Therapeutics Inc (GTHP)2025-12-31-$6.01Mn/m
QT Imaging Holdings, Inc. (QTI)2025-12-31$6.45Mn/m

Compare NRXS, ADMT, HCIL, NUWE side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗